Related Experiment Video
Updated: Jun 18, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Predicting cancer drug response: advancing the DREAM
1Departments of Bioengineering and Genetics, Stanford University, Stanford, California russ.altman@stanford.edu.
Cancer Discovery
|January 28, 2015
Summary
The DREAM challenge assesses systems biology methods for cancer drug sensitivity and synergism, revealing current approach limitations.
Area of Science:
- Systems biology
- Computational biology
- Cancer research
Background:
- The DREAM challenge is a community initiative to evaluate systems biology tools.
- Assessing computational approaches is crucial for advancing cancer research.
Purpose of the Study:
- To evaluate the performance of computational models in predicting cancer drug sensitivity.
- To identify strengths and weaknesses in current systems biology approaches for drug synergism prediction.
Main Methods:
- The study involved analyzing data from two specific DREAM challenges.
- Focus was on methods predicting drug sensitivity and drug synergism in cancer cells.
Main Results:
- Current systems biology approaches show varying capabilities in predicting drug response.
- Specific limitations were identified in predicting drug synergism compared to sensitivity.
Conclusions:
- The DREAM challenges highlight areas for improvement in computational systems biology for oncology.
- Further development is needed to enhance the accuracy of predictive models for cancer therapeutics.
Related Concept Videos
02:18Cancer
53.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.3K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
01:21Factors Affecting Drug Response: Overview
2.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K
01:21Cancer Survival Analysis
594
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
594